Larazotide (intestinal health) Article: Larazotide: potential for intestinal health Larazotide is a synthetic peptide that shows promise for strengthening intestinal tight junctions to prevent leaky gut syndrome, reducing passage of toxins, bacteria, and undigested food into the bloodstream that triggers inflammation and autoimmune responses
A Randomized, multicenter, open-label, blinded end point, phase 2, feasibility, efficacy, and safety trial of preoperative microvascular protection in patients undergoing major abdominal surgery
Stage 1 is characterized by a normal retina with hypopigmented fundus, whereas Stage 2 features the appearance of pigment clumping in the fovea with progressive retinal dysfunction (age-appropriate vision is unaffected)
Regulatory oversight is minimal in most jurisdictions, and compounded peptide sources lack standardized quality assurance comparable to FDA-regulated pharmaceuticals
A subset of cultured cells expressed GLP- 1 receptor, and mice with a-cell specific GLP- 1 receptor knockout have mild glucose intolerance and higher glucagon secretion in response to glucose challenges than animals of the wild type, which may indicate that GLP- 1 directly affects this cell [69]
Once reconstituted, store the solution at 2-8C and use within 30 days for optimal stability
